NCT06552676 riSk Factors fOR neCk phlEgmon afteR pErcutaneous tRacheostomy in ICU
| NCT ID | NCT06552676 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Azienda Usl di Bologna |
| Condition | Tracheostomy Complication |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2018-08-09 |
| Primary Completion | 2024-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2018-08-09 with a primary completion date of 2024-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Primary Purpose: To investigate the incidence and risk factors related to the appearance of tracheal phlegmon in patients undergoing percutaneous tracheostomy. Participant Population/Primary Condition: Patients admitted to Intensive Care Main Questions Aims to Answer: 1. \- What are the risk factors associated with the development of tracheal phlegmon percutaneous tracheostomy? 2. \- How does the appearance of tracheal phlegmon impact intensive care stay, hospital stay, mortality, and Health-related quality of life? Participants will be followed up after undergoing tracheostomy for 7 days to identify eventual phlegmons. At the two-year follow-up, the health-related quality of life will be assessed
Eligibility Criteria
Inclusion Criteria: * Age greater than 18 years * Presence of indication for tracheostomy Exclusion Criteria: * Failure of the percutaneous tracheostomy technique or recourse to surgical tracheostomy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06552676 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Tracheostomy Complication. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06552676 currently recruiting?
Yes, NCT06552676 is actively recruiting participants. Contact the research team at gamberini6@ausl.bologna.it for enrollment information.
Where is the NCT06552676 trial being conducted?
This trial is being conducted at Bologna, Italy.
Who is sponsoring the NCT06552676 clinical trial?
NCT06552676 is sponsored by Azienda Usl di Bologna. The trial plans to enroll 300 participants.